-Horizon Capital, con sede en Kiev, respalda a Notus Energy en el lanzamiento de un proyecto de energía eólica de 124 MW en Ucrania como la primera inversión de Horizon Capital Catalyst Fund, su fondo más nuevo

DAVOS, Suiza, 20 de enero de 2026 — Horizon Capital, firma líder de capital privado en Europa Emergente con 1.800 millones de dólares bajo gestión, anunció hoy el cierre inicial de su Horizon Capital Catalyst Fund (“HCCF”, “Fondo Catalyst”), centrado en la reconstrucción, junto con su primera transacción: respaldar a la empresa alemana Notus Energy para financiar un proyecto eólico de 124 MW en la región de Odesa, uno de los proyectos de energía renovable listos para construir más avanzados y mejor estructurados de Ucrania. Oleksii Sobolev, ministro de Economía, Medio Ambiente y Agricultura de Ucrania, asistió a ambas ceremonias de firma.

La transacción representa la primera inversión del recién lanzado Fondo Catalyst de Horizon Capital, que alcanzó más del 50% de su tamaño objetivo en el cierre inicial, 152 millones de euros de un total de 300 millones. El Fondo Catalyst proporciona entre 20 y 50 millones de euros de capital de crecimiento por inversión en sectores estratégicos con una gran cantidad de activos que requieren un capital significativo en la actualidad, como la energía, la infraestructura digital y la construcción.

El Fondo Catalyst adquirirá una participación del 45% en el Proyecto, que se espera movilice más de 220 millones de euros de inversión total, incluyendo un paquete de deuda estructurada liderado por instituciones financieras internacionales de desarrollo, como EBRD, IFC, Swedfund, BIO y Green for Growth Fund.

El Proyecto está siendo desarrollado por Notus Energy, una empresa alemana de energías renovables que ha implementado 1,6 GW de capacidad instalada a nivel mundial y se encuentra entre los proyectos de energías renovables más avanzados y mejor estructurados de Ucrania. El proyecto es el primero de tres parques eólicos en la cartera de proyectos a corto plazo de Notus Energy en Ucrania, que suma un total de aproximadamente 300 MW, y es parte de una cartera más amplia de desarrollo de energías renovables en Ucrania de más de 1,3 GW en proyectos en diferentes etapas.

Más allá de su importancia estratégica, el proyecto tiene un impacto ambiental, social y de gobernanza (ESG) sustancial: se espera que genere 378 GWh de electricidad limpia al año, suficiente para abastecer a 120.000 hogares, a la vez que reduce las emisiones de CO₂ en aproximadamente 244.000 toneladas al año. Además, creará más de 300 empleos durante la construcción y 50 puestos fijos, y cumple plenamente con los estándares internacionales de medio ambiente y seguridad, lo que garantiza prácticas de gobernanza y sostenibilidad de primer nivel.

Dmytro Boroday, socio de Horizon Capital y responsable del Fondo Catalyst, declaró: “Estamos encantados de unir fuerzas con Notus Energy para la implementación de su primer proyecto de energía eólica en Ucrania. Este proyecto es precisamente el tipo de proyecto financiable y de alta calidad que el Fondo Catalyst buscaba respaldar: moviliza capital a gran escala ahora, para un sector crucial de la economía ucraniana, establece un referente para los estándares internacionales en el sector energético y transmite un mensaje contundente de confianza en el futuro de Ucrania. La asociación con Notus Energy demuestra que Ucrania puede atraer inversores globales de alta calidad e inversiones sustanciales cuando los proyectos se estructuran según estándares internacionales, están protegidos por una sólida mitigación de riesgos y son desarrollados y respaldados por socios sólidos. Mediante el uso de capital catalítico, buscamos atraer capital de seguimiento sustancial a infraestructuras críticas que impulsarán la recuperación y el crecimiento a largo plazo de Ucrania“.

Heiner Dietmar Roger, fundador y consejero delegado de Notus Energy, comentó: “Nos honra asociarnos con Horizon Capital, ya que esta transacción marca un hito importante para Notus Energy en la implementación de nuestro primer proyecto en Ucrania. Con la inversión del Fondo Catalyst, contamos con el respaldo de capital necesario para seguir adelante con el proyecto de 124 MW, que proporcionará capacidad energética crítica, creará empleos técnicos altamente cualificados y contribuirá a los objetivos de sostenibilidad de Ucrania. Consideramos que Ucrania es un mercado con sólidos fundamentos para el despliegue de energías renovables, y esta transacción sienta las bases para que Notus Energy impulse nuestra cartera de desarrollo a medio plazo en Ucrania, con la ambición de alcanzar los 1,3 GW para 2030.

La implementación de la transacción está sujeta a la firma de los acuerdos definitivos y a las autorizaciones regulatorias correspondientes.

Acerca de Notus Energy 

Fundada en 2001, Notus Energy, empresa de gestión propia, es una empresa alemana que desarrolla, opera e invierte en proyectos de energía renovable en todo el mundo. Con operaciones en 18 países y una sólida cartera de proyectos eólicos y solares, Notus aporta una sólida experiencia técnica y un compromiso a largo plazo con el sector de las energías renovables de Ucrania.

Acerca de Horizon Capital 

Horizon Capital es la firma de capital privado líder en Europa Emergente, con más de 1.800 millones de dólares en activos bajo gestión (AUM) procedentes de inversores con una base de capital superior a los 700.000 millones de dólares. Su estrategia de inversión se centra en respaldar a emprendedores visionarios que lideran empresas de rápido crecimiento en Ucrania y Moldavia. Los fondos gestionados por Horizon Capital han invertido en más de 190 empresas que emplean a más de 56.000 personas. HCCF aspira a alcanzar su objetivo de 300 millones de euros y es un testimonio de la unión de instituciones en apoyo del prometedor futuro de Ucrania.

Foto – https://mma.prnewswire.com/media/2865284/Horizon_Capital_and_Notus_Energy.jpg
Logo – https://mma.prnewswire.com/media/2342850/5724043/Horizon_Capital_logo.jpg

DAVOS, Schweiz, 20. Januar 2026 — Horizon Capital, eine führende Private-Equity-Firma in den europäischen Schwellenländern mit einem verwalteten Vermögen von 1,8 Mrd. USD, gab heute den ersten Abschluss ihres auf den Wiederaufbau ausgerichteten Horizon Capital Catalyst Fund („HCCF”, „Catalyst Fund”) sowie dessen erste Transaktion bekannt: unterstützt die in Deutschland ansässige Notus Energy bei der Finanzierung eines 124-MW-Windkraftprojekts in der Region Odesa, das zu den fortschrittlichsten und am besten strukturierten baureifen Projekten für erneuerbare Energien in der Ukraine gehört. Oleksii Sobolev, Minister für Wirtschaft, Umwelt und Landwirtschaft der Ukraine, nahm an beiden Unterzeichnungszeremonien teil.

Die Transaktion ist die erste Investition aus dem neu aufgelegten Catalyst Fund von Horizon Capital, der beim Initial Closing mehr als 50 % seines Zielvolumens erreicht hat, nämlich 152 Mio. € von 300 Mio. €. Der Catalyst Fund stellt pro Investition 20 bis 50 Millionen Euro Wachstumskapital für strategische Sektoren mit hohem Kapitalbedarf zur Verfügung, darunter Energie, digitale Infrastruktur und Bauwesen.

Der Catalyst Fund wird einen Anteil von 45 % an dem Projekt erwerben, das voraussichtlich eine Gesamtinvestition von über 220 Mio. EUR mobilisieren wird, einschließlich eines strukturierten Schuldenpakets unter der Leitung internationaler Entwicklungsfinanzierungsinstitutionen, darunter EBRD, IFC, Swedfund, BIO und Green for Growth Fund.

Das Projekt wird von Notus Energy entwickelt, einem deutschen Unternehmen im Bereich der erneuerbaren Energien, das weltweit eine installierte Kapazität von 1,6 GW realisiert hat, und gehört zu den fortschrittlichsten und am besten strukturierten Projekten für erneuerbare Energien in der Ukraine. Das Projekt ist der erste von drei Windparks in der kurzfristigen Ukraine-Pipeline von Notus Energy mit einer Gesamtleistung von ca. 300 MW und Teil einer breiteren ukrainischen Entwicklungspipeline von über 1,3 GW für Projekte in verschiedenen Stadien.

Neben seiner strategischen Bedeutung hat das Projekt auch erhebliche Auswirkungen auf die ESG: Es wird erwartet, dass es jährlich 378 GWh sauberen Strom erzeugt, genug, um 120.000 Haushalte zu versorgen, und gleichzeitig die CO₂-Emissionen um etwa 244.000 Tonnen pro Jahr reduziert. Darüber hinaus werden während der Bauphase mehr als 300 Arbeitsplätze und 50 Dauerarbeitsplätze geschaffen. Das Projekt ist vollständig auf internationale E&S-Standards abgestimmt und gewährleistet eine erstklassige Unternehmensführung und Nachhaltigkeitspraxis.

Dmytro Boroday, Partner bei Horizon Capital und Leiter des Catalyst Fund: „Wir freuen uns sehr über die Zusammenarbeit mit Notus Energy bei der Umsetzung ihres ersten Windenergieprojekts in der Ukraine. Dieses Projekt ist genau die Art von qualitativ hochwertigen, bankfähigen Projekten, für die der Catalyst Fund eingerichtet wurde: Sie mobilisiert jetzt umfangreiches Kapital für einen kritischen Sektor der ukrainischen Wirtschaft, setzt einen Maßstab für internationale Standards im Energiesektor und sendet eine starke Botschaft des Vertrauens in die Zukunft der Ukraine. Die Partnerschaft mit Notus Energy zeigt, dass die Ukraine hochkarätige internationale Investoren und umfangreiche Investitionen anziehen kann, wenn die Projekte nach internationalen Standards strukturiert, durch eine solide Risikominderung geschützt und von starken Partnern entwickelt und unterstützt werden. Durch den Einsatz von katalytischem Eigenkapital wollen wir erhebliches Folgekapital in wichtige Infrastrukturen einbringen, die die Erholung und das langfristige Wachstum der Ukraine vorantreiben werden.”

Heiner Dietmar Roger, Gründer und CEO von Notus Energy, kommentierte: „Wir fühlen uns geehrt, mit Horizon Capital zusammenzuarbeiten, da diese Transaktion einen wichtigen Meilenstein für Notus Energy bei der Umsetzung unseres ersten Projekts in der Ukraine darstellt. Mit der Investition des Catalyst Fund verfügen wir über die nötige Eigenkapitalunterstützung, um das 124-MW-Projekt voranzutreiben, das wichtige Stromkapazitäten bereitstellt, hochqualifizierte technische Arbeitsplätze schafft und zu den Nachhaltigkeitszielen der Ukraine beiträgt. Wir sehen die Ukraine als einen Markt mit starken Grundlagen für den Einsatz erneuerbarer Energien, und diese Transaktion legt den Grundstein für Notus Energy, um unsere mittelfristige Entwicklungspipeline in der Ukraine voranzutreiben, mit dem Ziel, bis 2030 1,3 GW zu erreichen.”

Die Durchführung der Transaktion hängt von der Unterzeichnung der endgültigen Vereinbarungen und den üblichen behördlichen Genehmigungen ab.

Über Notus Energy

Das 2001 gegründete inhabergeführte Unternehmen Notus Energy ist ein in Deutschland ansässiger Entwickler, Betreiber und Investor von Projekten im Bereich der erneuerbaren Energien weltweit. Mit Niederlassungen in 18 Ländern und einer soliden Pipeline von Wind- und Solarprojekten verfügt Notus über fundiertes technisches Fachwissen und ein langfristiges Engagement im Bereich der erneuerbaren Energien in der Ukraine.

Über Horizon Capital

Horizon Capital ist die führende Private-Equity-Gesellschaft in den Schwellenländern Europas mit einem verwalteten Vermögen von über 1,8 Milliarden US-Dollar von Investoren mit einer Kapitalbasis von über 700 Milliarden US-Dollar. Die Anlagestrategie des Unternehmens konzentriert sich auf die Unterstützung visionärer Unternehmer, die schnell wachsende Unternehmen in der Ukraine und Moldawien leiten. Die von Horizon Capital verwalteten Fonds haben in über 190 Unternehmen mit mehr als 56.000 Beschäftigten investiert. Der HCCF strebt an, das angestrebte Fondsvolumen von 300 Millionen Euro zu erreichen, und ist ein Beweis dafür, dass sich Institutionen zusammenschließen, um die vielversprechende Zukunft der Ukraine zu unterstützen.

Foto – https://mma.prnewswire.com/media/2865284/Horizon_Capital_and_Notus_Energy.jpg
Logo – https://mma.prnewswire.com/media/2342850/5724043/Horizon_Capital_logo.jpg

DAVOS, Suisse, 20 janvier 2026 — Horizon Capital, une société de capital-investissement de premier plan dans l’Europe émergente avec 1,8 milliard de dollars sous gestion, a annoncé la clôture initiale de son fonds Horizon Capital Catalyst Fund (« HCCF », « Catalyst Fund ») axé sur la reconstruction, qui a eu lieu aujourd’hui, ainsi que sa première transaction : a soutenu la société Notus Energy, basée en Allemagne, pour financer un projet d’énergie éolienne de 124 MW dans la région d’Odessa, qui est l’un des projets d’énergie renouvelable prêts à être construits les plus avancés et les mieux structurés d’Ukraine. Oleksii Sobolev, ministre ukrainien de l’économie, de l’environnement et de l’agriculture, s’est joint aux deux cérémonies de signature.

Cette transaction représente le premier investissement du nouveau fonds Catalyst d’Horizon Capital, qui a atteint plus de 50 % de sa taille cible lors de la clôture initiale, soit 152 millions d’euros sur 300 millions d’euros. Catalyst Fund fournit 20 à 50 millions d’euros de capital de croissance par investissement dans des secteurs stratégiques à forte intensité d’actifs qui nécessitent aujourd’hui des capitaux importants, notamment l’énergie, l’infrastructure numérique et la construction.

Catalyst Fund prendra une participation de 45 % dans le projet, qui devrait mobiliser un investissement total de plus de 220 millions d’euros, y compris une dette structurée dirigée par des institutions internationales de financement du développement, notamment la BERD, la SFI, Swedfund, BIO et Green for Growth Fund.

Le projet est développé par Notus Energy, un acteur allemand du secteur des énergies renouvelables qui a mis en œuvre une capacité installée de 1,6 GW à l’échelle mondiale. Il s’agit de l’un des projets d’énergie renouvelable les plus avancés et les mieux structurés d’Ukraine. Le projet est le premier des trois parcs éoliens que Notus Energy prévoit de construire à court terme en Ukraine, pour un total d’environ 300 MW. Il fait partie d’un ensemble plus vaste de projets de développement d’énergies renouvelables en Ukraine, d’une capacité de plus de 1,3 GW, à différents stades d’avancement.

Au-delà de son importance stratégique, le projet a un impact ESG substantiel : il devrait produire 378 GWh d’électricité propre par an, soit suffisamment pour alimenter 120 000 ménages, tout en réduisant les émissions de CO₂ d’environ 244 000 tonnes par an. En outre, il créera plus de 300 emplois pendant la construction et 50 postes permanents, et il est entièrement conforme aux normes internationales en matière d’environnement et de sécurité, garantissant une gouvernance et des pratiques de développement durable de premier ordre.

Dmytro Boroday, partenaire d’Horizon Capital et responsable du Fonds Catalyst : « Nous sommes ravis de nous associer à Notus Energy pour la mise en œuvre de leur premier projet d’énergie éolienne en Ukraine. Ce projet est exactement le type de projet de haute qualité et bancable pour lequel le Fonds Catalyst a été conçu : elle mobilise dès à présent des capitaux à grande échelle pour un secteur essentiel de l’économie ukrainienne, établit une référence pour les normes internationales dans le secteur de l’énergie et envoie un message fort de confiance dans l’avenir de l’Ukraine. Le partenariat avec Notus Energy démontre que l’Ukraine peut attirer des investisseurs mondiaux de qualité et des investissements substantiels lorsque les projets sont structurés selon les normes internationales, protégés par une solide atténuation des risques, et développés et soutenus par des partenaires solides. En déployant des fonds propres catalytiques, nous visons à injecter des capitaux de suivi substantiels dans des infrastructures essentielles qui alimenteront la reprise et la croissance à long terme de l’Ukraine ».

Heiner Dietmar Roger, fondateur et PDG de Notus Energy, a commenté : « Nous sommes honorés de nous associer à Horizon Capital, car cette transaction marque une étape importante pour Notus Energy dans la mise en œuvre de notre premier projet en Ukraine. Grâce à l’investissement du Fonds Catalyst, nous disposons des fonds propres nécessaires pour mener à bien le projet de 124 MW , qui fournira une capacité énergétique essentielle, créera des emplois techniques hautement qualifiés et contribuera à la réalisation des objectifs de l’Ukraine en matière de développement durable. Nous considérons l’Ukraine comme un marché aux fondamentaux solides pour le déploiement des énergies renouvelables, et cette transaction permet à Notus Energy de faire avancer son projet de développement à moyen terme en Ukraine, avec l’ambition d’atteindre 1,3 GW d’ici à 2030. »

La mise en œuvre de la transaction est soumise à l’exécution des accords définitifs et aux autorisations réglementaires habituelles.

À propos de Notus Energy

Fondée en 2001, la société Notus Energy, gérée par son propriétaire, est une société allemande qui développe, exploite et investit dans des projets d’énergie renouvelable dans le monde entier. Présente dans 18 pays et disposant d’une solide réserve de projets éoliens et solaires, Notus apporte une expertise technique approfondie et un engagement à long terme au secteur ukrainien des énergies renouvelables.

À propos d’Horizon Capital

Horizon Capital est la société de financement par capitaux propres dans les pays émergents d’Europe avec plus de 1,8 milliard de dollars d’actifs sous gestion provenant d’investisseurs disposant d’un capital de plus de 700 milliards de dollars. La stratégie d’investissement de la société consiste à soutenir des entrepreneurs visionnaires à la tête d’entreprises en forte croissance en Ukraine et en Moldavie. Les fonds gérés par Horizon Capital ont été investis dans plus de 190 entreprises employant plus de 56 000 personnes. Le HCCF vise à atteindre son objectif de 300 millions d’euros et témoigne de l’union des institutions pour soutenir l’avenir prometteur de l’Ukraine.

Photo – https://mma.prnewswire.com/media/2865284/Horizon_Capital_and_Notus_Energy.jpg
Logo – https://mma.prnewswire.com/media/2342850/5724043/Horizon_Capital_logo.jpg

• N47 leads a $19M Series A raise, joined by Rackhouse Ventures, and Andreessen Horowitz.
• In XBuild’s first year, over 15,000 projects have been run to completion, $250M worth of construction projects.
• The company launches Roofing Proposals, a new product enabling anyone from a roofing company to generate a finished estimate in under 15 minutes.
• Founders bridge deep construction expertise with Silicon Valley product and engineering experience.

SAN FRANCISCO, Jan. 20, 2026 — Today, XBuild, the first AI platform purpose-built for construction, announced a $19 million Series A funding round led by N47 with participation from Rackhouse Ventures, and Andreessen Horowitz.

XBuild will use the funding to build the first vibe coding estimating platform for all of construction, scaling proposal capabilities into verticals including concrete, landscaping, painting, windows and doors, glass and glazing, insulation, HVAC, and plumbing.

Founded by former Uber and Postmates execs Jahan Khanna and Rob Moran, together with civil engineer Sharuk Khanna, XBuild combines technology and construction expertise to deliver exactly what contractors need.

Contractors struggle with pricing accuracy, cash‑flow gaps, homeowner skepticism, and scattered communication. XBuild tackles these pain points with an AI‑native estimating platform that’s agentic, chat‑based, and trained on the inputs roofers actually use—measurement reports and site photos—to produce standardized, editable estimates in minutes, with no demos or onboarding required.

After launching their first product last year, an insurance‑focused point solution:

• Over 15,000 projects have been run to completion
• $250M worth of construction projects
• Contractors have saved +40,000 hours creating estimates

XBuild’s new product, Roofing Proposals, brings the same experience to residential contractors and replaces legacy template‑driven estimating, drastically improving:

• Clear profit margins: Integrated with the industry’s largest material suppliers such as ABC Supply to provide real-time supplier pricing to ensure accurate costs.
• Measurement format hurdles: References PDF reports including EagleView, GAF QuickScope, Hover, and RoofR and supports manual photos including via CompanyCam, to create proposals in minutes.
• Homeowner transparency: Generates a homeowner link with Good/Better/Best pricing options, e-sign, and Stripe Connect payments for faster cash flow and straightforward buying process for the homeowner.

“Construction and the cost of building is the last space that truly has not been disrupted by technology in the way most of the rest of the world has,” said Jahan Khanna, Co-Founder of XBuild. “It is the final frontier, and in order to deal with the cost of living crisis all of us face today, it must become cheaper, faster, and easier to build things in the physical world.  XBuild and the coming AI revolution will be a catalyst to that end, and to a brighter future.”

“Estimating and proposal generation remain major bottlenecks for contractors, yet legacy tools haven’t kept pace with AI capabilities or the realities of how the industry works today,” said Matthew Cowan, General Partner at N47. “XBuild leverages deep industry expertise to deliver compelling automation and efficiency gains in construction, representing a cutting-edge application of AI to real-world problems.”

About XBuild
XBuild is the first true AI platform built for construction, helping contractors streamline their estimating process and win more jobs. The platform generates professional proposals that save contractors hours of manual work while improving accuracy. With features including the Insurance Estimation Copilot, Roofing Proposals, and flexible subscription plans, XBuild enables roofing contractors to respond faster to opportunities, reduce estimation costs, and scale their businesses more efficiently. XBuild is positioned to be a source of truth and transparency for both the contractor and homeowner. For more information, visit https://x.build/.

Media Contact:
Sarah Cohen
[email protected]

SOURCE XBuild

The invite-only gathering highlighted Edge’s unique transatlantic model, which enables medtech startups to conduct early-stage research and development in Israel before advancing clinical and commercial activities in the United States, contributing to highly differentiated, capital-efficient ventures. New Jersey is an increasingly attractive destination for companies seeking to establish and scale U.S. operations, with the state’s thriving network of hospitals, deep life sciences focus, and state-supported funding programs.

Opening the program, Edge Managing Partner Shai Policker outlined the firm’s dual venture studio and fund model and how it operates in the state:

“Our successful co-investment model with NJEDA through the NJ Innovation Evergreen Fund (NJIEF) has been instrumental in anchoring Edge portfolio companies to New Jersey,” said Shai Policker, Managing Partner, Edge Medical Ventures. “Edge builds companies around validated clinical needs and supports them with hands-on operational, clinical, regulatory, and U.S. go-to-market expertise from our New Jersey and Israel offices. By embedding these capabilities early on, we help startups progress efficiently toward clinical validation and commercialization.”

Paul Hoffmann, President and CEO of Liberty Science Center spoke about the institution’s expanding role as a convening platform for innovation, followed by remarks from Alexander Richter, Executive Director of the SciTech Innovation Hub, on SciTech Scity’s efforts to strengthen the region’s innovation ecosystem and attract high-growth tech companies.

A central theme of the event was the role of public-private collaboration in accelerating healthcare innovation. John Coelho and Alexander Pachman of the NJEDA discussed how state programs, including NJIEF, are helping attract investment, anchor companies locally, and retain high-growth life sciences companies and talent within the state.

“About three years ago, we created an investment thesis to intentionally diversify our state. We have moved from large companies to more of a connected ecosystem, diversified model,” said John Coelho, Senior Advisor, Life Sciences Strategic Innovation Centers, NJEDA. “Biotechnology is heavily dependent on medtech, and we see tremendous opportunity in both moving to the state.”

Edge is a Qualified Venture Fund of NJEDA’s Innovation Evergreen Fund, enabling co-investment alongside state capital into New Jersey-based medtech companies. Earlier last week, Edge portfolio company Synchrony Medical announced a $1M NJIEF investment through this model, on the back of Edge’s funding.

“We are here to work with entrepreneurs. We have one great example with Synchrony, and I hope we will have many, many more,” added Coelho.

A panel discussion featured three companies that were founded in Edge’s venture studio and are establishing themselves in New Jersey: Exero Medical, Urologic Health, and Synchrony Medical. Company representatives explored how operating through Edge’s model enables them to pair early-stage innovation and R&D in Israel, backed by the Israel Innovation Authority, with U.S.-based clinical, regulatory, and commercial progress—creating comprehensive transatlantic governmental support. Panelists shared recent milestones including completion of clinical studies, pilot programs, regulatory advancement, and early market activity.

The Innovation Showcase demonstrated how Edge’s venture creation and investment model is helping build and anchor successful medtech companies in New Jersey, reflecting broader momentum in the state’s healthcare innovation landscape as it becomes increasingly attractive to international startups through its proximity to major health systems, research institutions, investors, and state-supported funding programs.

About Edge Medical Ventures (Edge)

Edge Medical Ventures develops and invests in breakthrough medical technologies addressing critical unmet clinical needs through its venture studio and dedicated fund. With operations in both Israel and the United States, Edge combines financial investment with hands-on operational, clinical, regulatory, and U.S. go-to-market support to help medtech startups progress efficiently from concept through early commercialization.

Led by the management team of MEDX Xelerator, Israel’s leading medical device incubator, Edge’s experienced executives bring deep operating backgrounds across more than 20 medical technology companies, including successful exits and strategic partnerships, as well as extensive partnerships with healthcare systems and industry leaders. Based in Israel and New Jersey, Edge is backed by an S&P 500 strategic partner and supported by the Israel Innovation Authority and the New Jersey Economic Development Authority, reflecting its role in advancing cross-border innovation and accelerating patient-ready technologies into the U.S. healthcare market.

For more information, visit: https://edgemed.vc/

Photo – https://mma.prnewswire.com/media/2865413/MedTech_Innovation_Showcase.jpg

Media Contact:
Aviva Sapir
Number 10 Strategies
[email protected]

SOURCE Edge Medical Ventures

WASHINGTON, Jan. 20, 2026 — Andromeda Ventures today announced the official launch of its venture capital platform focused on mission-critical, dual-use technologies that strengthen infrastructure, security, and human performance on Earth while enabling sustainable human expansion into space. The firm will formally debut during SpaceCom | Space Congress 2026 in Orlando, where Co-Founder and General Partner Dr. Christyl C. Johnson will participate in a keynote fireside chat alongside Andromeda Ventures Operating Partners Clayton Turner and Daniel Fata on Friday, January 30, 2026.

Dr. Johnson’s conversation with Turner and Fata will focus on how validated government technology needs translate into scalable commercial capabilities — and how venture capital can accelerate that transition.

Andromeda Ventures invests from pre-seed through Series A across space, defense, energy, health, and AI-enabled autonomy. Unlike traditional venture funds that speculate on emerging trends, Andromeda invests against validated government technology roadmaps and clearly defined capability gaps, directing capital toward technologies that must perform reliably under extreme conditions.

The firm is led by Co-Founders and General Partners Dr. Christyl C. Johnson and Christian Elam, whose combined experience spans NASA executive leadership, venture investing, policy development, and global public-private partnerships.

“Many technologies required to operate in extreme environments also strengthen resilience here on Earth,” said Dr. Johnson. “Andromeda helps founders move faster from mission validation to deployable commercial solutions.”

Dr. Johnson previously served as Associate Administrator and Deputy Associate Administrator of NASA’s Space Technology Mission Directorate, where she provided executive leadership and strategic oversight of the Agency’s most advanced technology programs, spanning early research through flight-ready systems.

“We’re building an institution, not just a fund,” said Elam. “We bridge government requirements, frontier technology, and global capital so companies can scale into both public and commercial markets.”

Elam previously founded Bachmanity Capital and was an early investor in defense technology company Thor Dynamics. He co-authored the bipartisan Kids Online Safety Act and was appointed a United Nations Peace Ambassador in 2024.

Andromeda Ventures supports portfolio companies through validation pathways, regulatory insight, strategic partnerships, and international market entry via a global network. The firm expects to invest in approximately 30–35 companies, with a geographic focus of roughly 70% U.S. and 30% international investments.

About Andromeda Ventures

Andromeda Ventures invests where the future is being built — at the convergence of space exploration, defense modernization, and resilient infrastructure. Leveraging government-validated technology roadmaps, deep strategic partnerships, and an experienced leadership team, Andromeda backs mission-critical technologies that deliver immediate impact on Earth while enabling humanity’s expansion beyond.

For more information, visit www.andrventures.com or contact [email protected].

About SpaceCom | Space Congress

As the flagship event of Commercial Space Week, SpaceCom | Space Congress brings together the commercial sector, government agencies, and academia to share ideas, form partnerships, close deals, and advance the technologies and strategies shaping our future in space.

For more information, visit www.spacecomexpo.com.

Media Contact:

Tony Chamblee
[email protected]
+13107704313

SOURCE Andromeda Ventures

NEW YORK, Jan. 20, 2026 — Formulary Financial, a full-service, AI-native fund administrator, today announced it has emerged from stealth with $4.6 million in seed funding led by Khosla Ventures, with participation from Acrew Capital, Company Ventures, Human Ventures, Serena Ventures, and Alumni Ventures, among other strategic partners and industry executives.

Formulary offers comprehensive fund administration services across the investment lifecycle — including accounting, reporting, compliance, audit, capital activity, and investor communications — powered by an AI-native platform designed to keep the data accurate, synthesized, and accessible in real time.

The need for reliable data, intelligent operations, and personalized advice

More than $23 trillion in private markets capital is still managed with erroneous spreadsheets, outdated software, and expensive shadow fund administration processes. Incumbent providers keep trying to retrofit legacy infrastructure with modern tools, and new software solutions are experimenting with agentic workflows to replace accountants. But the underlying problem is unsolved: the data remains unreliable and fragmented, and the need for expert fund administration support has only become more critical as asset managers grow in size and complexity.

The fund administration industry also faces a major bottleneck — accountants spend up to 70% of their time on repetitive administrative work and error-prone data entry instead of serving general partners and limited partners. This creates a massive drag on productivity and prevents investors from getting timely, accurate data and high-quality service. As a result, GPs waste time validating their own fund data and LPs receive late or inaccurate reporting. Lack of adequate fund administration support throughout the investment lifecycle could also result in other unnecessary costs and risks, from compliance issues and regulatory penalties to lost investor trust.

Formulary replaces these fragmented systems with a structured data foundation and a modern client experience.

• One Source of Truth. Single platform integrates external and internal data sources, eliminates the need for disparate tools, and delivers an auditable, holistic view of an asset management firm.
• Real-Time Reporting. Records are updated, gated, and tracked immediately, not quarterly, to give investors timely information to make decisions.
• Personalized Investor Service. Embedding AI into workflows enables accountants to focus on value-add activities, deep problem-solving, and strategic advisory for general partners and limited partners alike.

Alfia Ilicheva, founder and CEO of Formulary, said:

“We founded Formulary to transform fund administration from a pain point into a strategic advantage for asset managers. At Bridgewater Associates, I saw firsthand the power of a systematic, data-driven approach to develop a rich understanding of global markets and deliver thought partnership to the world’s largest, most sophisticated investors. We are now bringing data systemization to private capital markets, where operational infrastructure has long lagged behind the needs of investors.”

“Today, fund administration is defined by manual reconciliation, poor data quality, and massive opportunity cost. Most firms run redundant parallel accounting processes to manage their capital flows. Formulary reimagines fund administration from the ground up, where AI powers fund accounting workflows, accelerates productivity, and generates tailored insights for clients.”

Formulary’s clients and design partners manage billions in AUM

Formulary already works with a broad range of leading asset managers that use the platform to keep their data accurate, reduce manual work, and accelerate reporting cycles, giving GPs and LPs real-time visibility into performance metrics.

Hari Arul of Khosla Ventures said:

“To modernize fund administration, AI cannot be a feature, it has to be the foundation. The Formulary team is strategically positioned at the intersection of investment management, AI/ML, and fund accounting. Importantly, they are solving the fundamental issue of unreliable, inconsistent data. Their early customers are already seeing the value of a platform designed for accuracy from day one, and we are excited to back their vision.”

In practice, Formulary turbocharges accountants by enabling them to complete fund administration processes end-to-end in a unified platform. From generating financial statements and custom reports to managing capital activity and invoices, Formulary streamlines work that takes the most time and creates the most errors across the industry. 

About Formulary Financial

Formulary Financial, Inc. is a full-service, AI-native fund administration business serving private equity, growth equity, and venture capital firms. Built by a team of experts in asset management, fund accounting, and artificial intelligence, Formulary transforms fund administration from error-prone paperwork into reliable data, intelligent fund operations, and tailored insights to help investors manage and grow their businesses. The company was founded in 2025 and is based in New York City. To learn more, visit: www.formulary.co.

About Khosla Ventures

Khosla Ventures is a venture capital firm focused on investments in artificial intelligence, financial services, healthcare, consumer, enterprise, and sustainability. It is known for making early capital investments in startups such as OpenAI, Instacart, Affirm, DoorDash, and Block. To learn more, visit: https://www.khoslaventures.com/

Media Contact: [email protected]

SOURCE Formulary Financial, Inc.

Funding will advance the company’s internal pipeline of first-in-class programs

BOULDER, Colo., Jan. 20, 2026 — Think Bioscience (“Think Bio”), a biotechnology company focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series A. The round was led by Regeneron Ventures, Innovation Endeavors, and Janus Henderson Investors with participation from T.A. Springer, CE-Ventures, MBX Capital, and YK Bioventures. Returning investors include AV8 Ventures, CU Innovations, and Buff Gold Ventures.

Think Bioscience develops small molecule drugs for historically challenging drug targets by using synthetic biology to uncover novel footholds for medicinal chemistry (e.g., protein pockets). Their lead program targets mutants that cause Noonan syndrome, a genetic condition that affects approximately 1 in 2,500 births. Noonan patients experience life-threatening cardiac and lymphatic issues, short stature, cognitive impairment, and pain, among other chronic symptoms. There are no approved therapies that address the underlying biology of this disease.

“Our lead program has the potential to give a broad set of Noonan patients a better life,” said Dr. Jerome Fox, co-founder and CEO at Think Bioscience. “We are grateful to our investors for supporting our vision to develop life-changing therapies.”

Despite recent advances in computational chemistry, drug design remains exceedingly difficult. Most proteins in the human proteome are still considered undruggable—that is, they lack an obvious pocket for a drug to bind. Think Bio’s synthetic biology platform uses high-throughput functional surveys to find pockets that others miss and uses them to advance small molecules with biochemical activities previously deemed difficult, if not impossible, to achieve. They have extended their platform to a striking variety of targets, including transcription factors, protein phosphatases, kinases, proteases, and GTPases, while advancing a robust internal pipeline.

“This team is succeeding where others have failed. The lead program is the best example, but just one of many that the company is prosecuting. We are enthusiastic to double down.” said Nick Olsen, Partner at Innovation Endeavors.

About Think Bioscience

Think Bioscience is a privately held small molecule drug discovery company based in Boulder, Colorado. They are focused on developing therapeutics against targets that have historically been considered “undruggable”. The company’s team combines expertise in synthetic biology, protein biophysics, applied enzymology, computational chemistry, and medicinal chemistry to launch first-in-class program for diseases with high unmet need. Learn more at www.thinkbioscience.com.

SOURCE Think Bioscience

Platform delivers 25% connect rates for sales teams—6x the industry average—without adding headcount or changing tech stacks

KNOXVILLE, Tenn., Jan. 20, 2026 — TitanX, the Phone Intent™ platform that tells sales teams who will answer before they dial, today announced a $27 million Series A financing from Updata Partners.

TitanX has emerged as the category-defining platform in Phone Intent™, powered by a proprietary scoring model that solves one of outbound sales’ most persistent and expensive challenges: the 97% of calls that go unanswered. By predicting which prospects are most likely to pick up, the platform consistently delivers 25%+ connect rates, enabling sales teams to generate more conversations, build more pipeline, close more deals, and scale outbound motions without adding headcount or overhauling existing systems.

The investment follows a period of exceptional growth for TitanX, including more than 250% year-over-year revenue growth, rapid adoption across mid-market and enterprise organizations, and accelerating momentum as outbound teams face increasing go-to-market headwinds. Since launch, TitanX has established a clear first-mover advantage in Phone Intent™, underpinned by a defensible scoring model and operational discipline rarely seen at this stage of company maturity.

“We’ve spent the last 19 months executing with near-perfect discipline on a vision to transform go-to-market,” said Joey Gilkey, Founder and CEO of TitanX. “This wasn’t about raising capital — it was about choosing the right partner. Updata shares our conviction that TitanX doesn’t chase market parity. We define the standard for modern revenue execution.”

The Series A capital will support TitanX’s next phase of growth, including expansion of its proprietary scoring platform, deeper integrations across outbound sales workflows, new products designed for phone-led revenue teams, and strategic M&A.

“Creating a new category is rare – and even harder in a market where outbound teams are under real pressure,” said Braden Snyder, General Partner at Updata Partners. “We have been impressed by TitanX’s ability to build the Phone Intent™ category as a bootstrapped company executing at an exceptional level. As volume-based outbound becomes less effective, TitanX has purpose-built a software and data platform that addresses the core inefficiencies in outbound sales. We believe TitanX is positioned to become foundational to modern outbound execution.”

TitanX enters this next chapter with a leadership team typically seen at Series B and beyond, a rapidly expanding enterprise customer base, and a proven ability to execute at scale. As revenue organizations face mounting pressure to do more with fewer resources, TitanX is positioning itself as the intelligence layer for modern outbound.

To learn how TitanX helps teams unlock more conversations and real pipeline impact, visit titanx.io.

About TitanX

TitanX is the Phone Intent™ platform that predicts which prospects will answer cold calls before reps dial. Founded in 2024 and headquartered in Knoxville, TN, the company has grown to 300+ customers through word of mouth alone, helping sales teams achieve 25% connect rates versus the 4% industry average—without changing their tech stack, data provider, or dialer. TitanX transforms sales teams from voicemail robots into conversation machines.

Media Contact:
Emma Green
[email protected]
262.443.9557

SOURCE TitanX